Clinical characteristics and outcomes of diabetes‐related ketoacidosis (DKA) in sodium‐glucose co‐transporter‐2 inhibitor (SGLT2i) users with type 2 diabetes
View Full Paper
Ask AI
Bookmark
Share
Key Points
SGLT2i users experienced similar clinical outcomes despite more pronounced acidosis during DKA episodes.
Key findings reveal that SGLT2i was the sole precipitant in 30.3% of DKA cases; education on risk is critical.
The retrospective cohort study included data from 18 UK hospitals and matched users and non-users for comparison.
Timely interventions and risk factor education are essential for managing diabetes related ketoacidosis with SGLT2i.
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Retrospective cohort analysis on diabetes related ketoacidosis in SGLT2i users, revealing significant clinical outcomes.